文献速递乳腺US

超声造影对乳腺导管内病变诊断效能的多层次医师研究

Diagnostic Efficacy of Contrast-Enhanced Ultrasound for Breast Intraductal Lesions: A Multi-Modal Physician Experience Study.
PubMed 文献 · J Ultrasound Med · 2026-07-20

本研究纳入205例经病理证实的乳腺导管内病变患者,比较常规超声、超声造影及二者联合在不同年资医师中的诊断效能。以病理为金标准,联合模式在各级医师中诊断效能和信心评分均显著优于单一模式,对不典型导管增生和导管原位癌等易漏诊病变改善最明显。

要点

  • 超声联合超声造影可提高各级医师对乳腺导管内病变良恶性的鉴别能力。
  • 联合模式对低年资医师帮助最大,尤其减少不典型导管增生和导管原位癌漏诊。
  • 同一种检查方案下,诊断效能随医师年资降低而下降。

核心结论

  • 超声造影是乳腺导管内病变诊断的有价值辅助工具,对低年资和中年资医师尤有帮助。
  • 常规超声与超声造影联合诊断模式能提升整体诊断效能。

研究设计与样本

  • 纳入2022年1月至2025年9月接受常规超声和超声造影检查、并经病理证实为乳腺导管内病变的患者。
  • 以病理结果为金标准,比较高年资、中年资、低年资医师在三种检查方案下鉴别良恶性病变的效能。

关键影像表现/征象

  • 联合超声与超声造影对不典型导管增生和导管原位癌等易漏诊病变的诊断改善更突出。

诊断标准与关键数值

  • 联合模式在高年资医师组中诊断效能最优(p < .001)。
  • 联合模式带来的提升幅度在低年资医师中最大(p < .001)。
  • 在任意检查方案下,诊断效能随医师经验降低呈下降趋势(p < .05)。

临床应用与阅片要点

  • 日常阅片中可优先采用常规超声联合超声造影对乳腺导管内病变进行定性评估。
  • 低年资和中年资医师报告乳腺导管内病变时更适合借助超声造影辅助判断。
  • 遇到疑似不典型导管增生或导管原位癌时,应主动结合超声造影表现以减少漏诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the diagnostic efficacy of 3 imaging modalities-conventional ultrasound (US), contrast-enhanced ultrasound (CEUS), and their combination (US + CEUS)-among physicians with varying experience levels in diagnosing breast intraductal lesions and to elucidate the adjunctive value of CEUS.

METHODS: This study included patients who underwent both US and CEUS for breast lesions and were subsequently pathologically confirmed to have intraductal breast lesions between January 2022 and September 2025. Using pathological findings as the gold standard, the efficacy of senior, mid-career, and junior physicians in differentiating benign from malignant intraductal lesions was calculated and compared across the 3 diagnostic modalities.

RESULTS: A total of 205 cases were included, comprising 117 benign and 88 malignant lesions. The combined US + CEUS approach demonstrated significantly superior diagnostic efficacy and higher diagnostic confidence scores compared to either CEUS or US alone among physicians at all experience levels. The combined modality yielded optimal efficacy in the senior physician group (p < .001), while the magnitude of improvement was greatest among junior physicians (p < .001), particularly for easily missed lesions like atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS). For any given examination protocol, diagnostic efficacy exhibited a declining trend with decreasing physician experience (p < .05).

CONCLUSION: CEUS serves as a valuable adjunctive tool for diagnosing breast intraductal lesions and is particularly beneficial for junior and mid-career physicians. The combined diagnostic approach enhances overall diagnostic performance.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Yang, Gou, Jia, et al. Diagnostic Efficacy of Contrast-Enhanced Ultrasound for Breast Intraductal Lesions: A Multi-Modal Physician Experience Study. J Ultrasound Med. 2026. PMID: 42475158. doi:10.1002/jum.70333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。